https://www.zacks.com/stock/news/2222152/carlisle-csl-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2222152
Feb 06, 2024 - Carlisle (CSL) delivered earnings and revenue surprises of 20.17% and 3.92%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:273109589102151336
0
https://seekingalpha.com/news/4065708-csl-limited-stock-falls-after-phase-3-setback?source=feed_sector_healthcare
Feb 12, 2024 - Australian biotech CSL Limited (CSLLY) experienced a 4% intraday loss after its Phase 3 AEGIS-II trial, aimed at reducing cardiovascular events, failed.
0
sa:1496509908254401699
0
https://www.zacks.com/stock/news/2228924/3-stocks-to-buy-out-of-the-top-rated-zacks-diversified-operations-industry?cid=CS-ZC-FT-video_blog-2228924
Feb 20, 2024 - The growth prospects of these Zacks Diversified Operations Industry stocks are very intriguing considering their reasonable valuations.
zc:-7852844338444116250
0
https://www.zacks.com/stock/news/2232484/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2232484
Feb 27, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zc:2949653874909805734
0
https://www.zacks.com/stock/news/2241573/itt-gains-from-end-market-strength-buyouts-amid-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2241573
Mar 15, 2024 - ITT gains from strength in energy, mining and decarbonization markets, Svanehoj buyout and shareholder-friendly policies. However, softness in the global auto market is concerning.
zc:-5380738715009719336
0
https://www.zacks.com/stock/news/2243042/here-s-why-you-should-hold-3m-mmm-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|zer_report_update-2243042
Mar 19, 2024 - 3M (MMM) gains from solid momentum in its Transportation and Electronics segment, buyouts and shareholder-friendly policies. Softness in the Consumer segment remains concerning.
zc:2142403711764277051
0
https://www.zacks.com/stock/news/2242830/why-carlisle-csl-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2242830
Mar 19, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zc:-7122354556136235812
0
https://www.zacks.com/stock/news/2243583/here-s-why-carlisle-csl-stock-is-an-attractive-pick-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243583
Mar 20, 2024 - Carlisle (CSL) is set to benefit from continued demand for reroofing products and accretive acquisitions. Its measures to reward its shareholders are noteworthy.
zc:7953948475796485196
0
https://www.zacks.com/stock/news/2254795/reasons-why-danaher-dhr-should-be-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2254795
Apr 12, 2024 - Danaher (DHR) is set to benefit from strength across its businesses, acquired assets and shareholder-friendly policies.
zc:-9069135443860264351
0
https://www.zacks.com/stock/news/2257902/danaher-dhr-gears-up-to-post-q1-earnings-is-a-beat-likely?cid=CS-ZC-FT-analyst_blog|earnings_preview-2257902
Apr 18, 2024 - Danaher's (DHR) Q1 earnings are likely to be hurt by weakness in the Biotechnology unit. Improving supply chains and strong price realization are expected to be positives.
zc:9012505763518735607
0